PT1501774E - Aldeídos lineares polinsaturados e seus derivados com actividade anti-radicalar - Google Patents
Aldeídos lineares polinsaturados e seus derivados com actividade anti-radicalar Download PDFInfo
- Publication number
- PT1501774E PT1501774E PT03749867T PT03749867T PT1501774E PT 1501774 E PT1501774 E PT 1501774E PT 03749867 T PT03749867 T PT 03749867T PT 03749867 T PT03749867 T PT 03749867T PT 1501774 E PT1501774 E PT 1501774E
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- linear aldehydes
- polyunsaturated linear
- radical activity
- prevention
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/21—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000960A ITMI20020960A1 (it) | 2002-05-07 | 2002-05-07 | Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1501774E true PT1501774E (pt) | 2009-10-15 |
Family
ID=11449841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03749867T PT1501774E (pt) | 2002-05-07 | 2003-05-06 | Aldeídos lineares polinsaturados e seus derivados com actividade anti-radicalar |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050175555A1 (pt) |
EP (1) | EP1501774B9 (pt) |
AT (1) | ATE439338T1 (pt) |
AU (1) | AU2003232722A1 (pt) |
CY (1) | CY1109512T1 (pt) |
DE (1) | DE60328769D1 (pt) |
DK (1) | DK1501774T3 (pt) |
ES (1) | ES2329890T3 (pt) |
IT (1) | ITMI20020960A1 (pt) |
PT (1) | PT1501774E (pt) |
SI (1) | SI1501774T1 (pt) |
WO (1) | WO2003095403A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
CN1646140A (zh) * | 2002-02-04 | 2005-07-27 | 阿尔法玛药品研发有限公司 | 可释放co的化合物在用于治疗炎症药物的制备中的应用 |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
WO2007073226A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Method for treating a mammal by administration of a compound having the ability to release co |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
GB0605900D0 (en) | 2006-03-23 | 2006-05-03 | Lipigen As | Modulators of nuclear receptors |
WO2009110983A2 (en) * | 2008-02-29 | 2009-09-11 | The Brigham And Women's Hospital, Inc. | Retinaldehyde in the treatment of obesity, diabetes and other conditions |
IT1394921B1 (it) * | 2008-11-10 | 2012-07-27 | Giuliani Spa | Uso di composti come principi attivi per migliorare l'azione di riparazione cellulare dell'epidermide umana, e composizioni farmaceutiche e cosmetiche che li contengono |
IT1391663B1 (it) * | 2008-11-10 | 2012-01-17 | Giuliani Spa | Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono |
EP2241543A1 (en) * | 2009-04-17 | 2010-10-20 | Giuliani S.p.A. | Process for the preparation of 2,4,6-octatriene-1-oic acid and 2,4,6-octatriene-1-ol |
IT1401289B1 (it) * | 2010-04-22 | 2013-07-18 | Giuliani Spa | Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono |
EP2407163A1 (en) | 2010-07-16 | 2012-01-18 | Giuliani S.p.A. | Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them |
WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドAlfama,Inc. | 一酸化ルテニウム放出分子およびその使用 |
CN117229132B (zh) * | 2023-11-10 | 2024-02-20 | 济南悟通生物科技有限公司 | 一种反式-2,4-壬二烯醛的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679792A (en) * | 1969-09-05 | 1972-07-25 | Wrigley W M Jun Co | Dialdehyde-containing anti-caries chewing gum compositions |
DE10200130A1 (de) * | 2002-01-04 | 2003-07-10 | Basf Ag | Verfahren zur Herstellung von Polyendialdehydmonoacetalen |
-
2002
- 2002-05-07 IT IT2002MI000960A patent/ITMI20020960A1/it unknown
-
2003
- 2003-05-06 AU AU2003232722A patent/AU2003232722A1/en not_active Abandoned
- 2003-05-06 ES ES03749867T patent/ES2329890T3/es not_active Expired - Lifetime
- 2003-05-06 US US10/513,450 patent/US20050175555A1/en not_active Abandoned
- 2003-05-06 PT PT03749867T patent/PT1501774E/pt unknown
- 2003-05-06 DK DK03749867T patent/DK1501774T3/da active
- 2003-05-06 DE DE60328769T patent/DE60328769D1/de not_active Expired - Lifetime
- 2003-05-06 SI SI200331667T patent/SI1501774T1/sl unknown
- 2003-05-06 AT AT03749867T patent/ATE439338T1/de active
- 2003-05-06 WO PCT/EP2003/004720 patent/WO2003095403A1/en not_active Application Discontinuation
- 2003-05-06 EP EP03749867A patent/EP1501774B9/en not_active Expired - Lifetime
-
2009
- 2009-10-21 CY CY20091101096T patent/CY1109512T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SI1501774T1 (sl) | 2009-12-31 |
ES2329890T3 (es) | 2009-12-02 |
CY1109512T1 (el) | 2014-08-13 |
EP1501774B9 (en) | 2010-02-24 |
EP1501774A1 (en) | 2005-02-02 |
AU2003232722A1 (en) | 2003-11-11 |
EP1501774B1 (en) | 2009-08-12 |
ATE439338T1 (de) | 2009-08-15 |
DK1501774T3 (da) | 2009-12-14 |
ITMI20020960A1 (it) | 2003-11-07 |
ITMI20020960A0 (it) | 2002-05-07 |
WO2003095403A1 (en) | 2003-11-20 |
US20050175555A1 (en) | 2005-08-11 |
DE60328769D1 (de) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1501774E (pt) | Aldeídos lineares polinsaturados e seus derivados com actividade anti-radicalar | |
WO2007001883A3 (en) | Method to reduce oxidative damage and improve mitochondrial efficiency | |
MX2008006589A (es) | Composiciones de edulcorante natural de mesa, de alta potencia, con perfil temporal y/o de sabor mejorado, metodos para su formulacion, y usos | |
IS8418A (is) | 1,4-tvíútskiptar ísókínílónafleiður sem RAF-kínasatálmar sem eru gagnlegar til að meðhöndla fjölgunarsjúkdóma | |
EP2003196A3 (en) | Compositions and methods for treating and diagnosing cancer | |
EP1883416A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS RELATED TO INFLAMMATION | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2009099719A3 (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
WO2009132174A3 (en) | Methods and compositions for improving the nutritional content of mushrooms and fungi | |
EP2385062A3 (en) | Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer | |
WO2006017134A3 (en) | Preprimitive streak and mesendoderm cells | |
MX338235B (es) | Microorganismos eucarioticos para producir lipidos y antioxidantes. | |
WO2009070244A3 (en) | Methods for inhibiting fascin | |
WO2010138492A3 (en) | Dentifrice composition | |
MX339842B (es) | Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas. | |
ATE528013T1 (de) | Impfstoff-zusammensetzungen | |
MX2011005370A (es) | Formas de dosis orales de sufentanilo que comprenden agentes barredores de oxígeno y métodos de uso de los mismos. | |
WO2004112829A3 (en) | Compositions and methods for the diagnosis and treatment of tumors of glial origin | |
WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
MX2007011493A (es) | Modalidades antiinflamatorias. | |
PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
NZ580533A (en) | Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods | |
NZ595440A (en) | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds | |
MX2011011860A (es) | Composicion estimulante inmune que comprende un extracto de aronia sp. en combinacion con selenio y/o zinc. | |
WO2004064719A3 (en) | Synergistic compositions and methods for potentiating anti-oxidative activity |